GlaxoSmithKline (JOBS) Wins U.S. Approval for Swine Flu Vaccine

Bookmark and Share

Reuters -- GlaxoSmithKline Plc (GSK.L) has won U.S. marketing approval to sell an unadjuvanted H1N1 swine vaccine, allowing it to ship relatively modest amounts of scarce vaccine to the United States next month.

MORE ON THIS TOPIC